High-throughput screens identify HSP90 inhibitors as potent therapeutics that target inter-related growth and survival pathways in advanced prostate cancer

Keith H. Jansson, Kathleen Kelly, John B. Tucker et al.|Scientific Reports|2018

Cited by 33